首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Protective effect of lodoxamide on hepatic steatosis through GPR35
Institution:1. Department of Hepatopancreatobiliary Center, The Third Hospital Affiliated to Nantong University, Wuxi City, Jiangsu Province, China;2. Department of General Surgery, Huai’an Hospital Affiliated to Xuzhou Medical University, Huai''an, China;3. Department of General Surgery, The Second People’s Hospital of Wuhu, Wuhu, China;1. The Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China;2. Jiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu 215021, China;3. The Center of Diagnosis and Treatment for Children’s Bone Diseases, The Children’s Hospital Affiliated to Soochow University, Suzhou, Jiangsu 215000, China;1. Department of Clinical and Experimental Medicine, University of Sassari, 07100 Sassari, Italy;2. Institute of Pathology, Universitätsmedizin Greifswald, 17489 Greifswald, Germany;3. Institute of Pathology, University of Regensburg, 93053 Regensburg, Germany;1. The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, 30 Hudemulin Rd, Baotou 014030, China;2. Laboratory of Gastrointestinal Injury and Cancer, VA Long Beach Healthcare System, Long Beach, CA 90822, USA;3. College of Medicine, University of California Irvine, CA 92697, USA;1. Department of Pathology, Affiliated Cancer Hospital of Nantong University, Nantong, 226001 Jiangsu, People’s Republic of China;2. Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Medical College, Nantong University, Nantong, 226001 Jiangsu, People’s Republic of China;3. Affiliated Cancer Hospital of Nantong University, Nantong, 226001 Jiangsu, People’s Republic of China
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号